-

Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers’ success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

Contacts

Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137

Novanta Inc.

NASDAQ:NOVT

Release Versions

Contacts

Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137

More News From Novanta Inc.

Novanta’s Board of Directors Authorizes Additional $200 Million for Share Repurchase Program

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the repurchase of up to an additional $200 million of the Company’s outstanding common shares, adding capacity to the $31 million remaining from its 2020 Board authorization, for a total capacity of $231 million. “The Board’s action reflects continued confidence in the Company’s f...

Novanta Announces Financial Results for the Second Quarter 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) June 27,     June 28,     2025     2024   GAAP           Revenue $ 241.0     $ 235.9   Operating Income $ 14.9     $ 25.7   Net Income $ 4.5     $ 13.8   Diluted EPS $ 0.12     $ 0.38...

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025. The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a li...
Back to Newsroom